Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Moon Lake Immunotherapeutics Transaction History
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.
- $615 Billion
- Q2 2024
A detailed history of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds 228,803 shares of MLTX stock, worth $11.3 Million. This represents 1.64% of its overall portfolio holdings.
Number of Shares
228,803
Previous 229,230
0.19%
Holding current value
$11.3 Million
Previous $11.5 Billion
12.63%
% of portfolio
1.64%
Previous 1.78%
Shares
3 transactions
Others Institutions Holding MLTX
# of Institutions
127Shares Held
58MCall Options Held
103KPut Options Held
79.7K-
Bvf Inc San Francisco, CA21.8MShares$1.07 Billion29.25% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$420 Million28.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$137 Million1.66% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.56MShares$127 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.27MShares$112 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.82B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...